Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05938699 · ClinicalTrials.gov registry record · Phase 2
Aqueous Humor Dynamics of NCX 470 Ophthalmic Solution
A Phase 2 study, sponsored by Nicox Ophthalmics.
- Completed
- Registry status
- Phase 2
- Development phase
- 18
- Enrollment target
NCT05938699 is a Phase 2 study that has completed, run by Nicox Ophthalmics. The registered enrollment target is 18 participants.
The verdict
NCT05938699, a Phase 2 study, has completed, sponsored by Nicox Ophthalmics.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 18 participants
- Enrollment target
Study Summary
This is a double-masked, placebo-controlled study which will determine the action of NCX 470 ophthalmic solution, 0.1% on aqueous humor dynamic parameters in healthy volunteers or subjects with OHT.
Interventions
- DRUG Placebo
- DRUG NCX 470
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2023-12-12 |
| Est. Completion | 2025-03-17 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05938699
The ClinicalTrials.gov registry entry for NCT05938699 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Nicox Ophthalmics, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT05938699 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05938699 about?
NCT05938699 is a clinical study titled "Aqueous Humor Dynamics of NCX 470 Ophthalmic Solution". This is a double-masked, placebo-controlled study which will determine the action of NCX 470 ophthalmic solution, 0.1% on aqueous humor dynamic parameters in healthy volunteers or subjects with OHT.
What is the current status of trial NCT05938699?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 18 participants. The study started on 2023-12-12. Estimated completion is 2025-03-17.
What interventions are being tested in trial NCT05938699?
The interventions under investigation include: Placebo (DRUG), NCX 470 (DRUG).
Who is sponsoring clinical trial NCT05938699?
This trial is sponsored by Nicox Ophthalmics, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.